Risk factors, DNA damage, and disease progression in Barrett's esophagus

Cancer Epidemiology Biomarkers and Prevention

Volumn 14, Issue 3, 2005, Pages 620-625

  Olliver, Joanna R ^a   Hardie, Laura J ^a   Gong, YunYun ^a   Dexter, Simon ^b   Chalmers, Douglas ^c   Harris, Keith M ^b   Wild, Christopher P ^a,b  

^a Landscape Group   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIINFLAMMATORY AGENT; DNA; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR;

ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; CANCER RISK; COMET ASSAY; CONTROLLED STUDY; DISEASE COURSE; DNA DAMAGE; DYSPLASIA; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS MUCOSA; FEMALE; GASTROESOPHAGEAL REFLUX; GENETIC STABILITY; GENOTOXICITY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; SMOKING; STOMACH MUCOSA;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BARRETT ESOPHAGUS; CASE-CONTROL STUDIES; COMET ASSAY; DISEASE PROGRESSION; DNA DAMAGE; ESOPHAGEAL NEOPLASMS; FEMALE; GASTRIC MUCOSA; GASTROESOPHAGEAL REFLUX; HUMANS; MALE; MIDDLE AGED; RISK FACTORS;

EID: 16844382117     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-04-0509     Document Type: Article

References (29)

1. Jankowski JA, Harrison RF, Perry I, Balkwill F, Tselepis C. Barrett's metaplasia. Lancet 2000;356:2079-85.
2. Chen XX, Yang CS. Esophageal adenocarcinoma: a review and perspectives on the mechanism of carcinogenesis and chemoprevention. Carcinogenesis 2001;22:1119-29.
3. Wild CP, Hardie LJ. Reflux, Barrett's oesophagus and adenocarcinoma: burning questions. Nat Rev Cancer 2003;3:676-84.
4. Lagergren J, Bergstrom R, Lindgren A, Nyren O. Symptomatic gastro-esophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999;340:825-31.
5. Mayne ST, Risch HA, Dubrow R, et al. Nutrient intake and risk of subtypes of esophageal and gastric cancer. Cancer Epidemiol Biomarkers Prev 2001;10:1055-62.
6. Chen HL, Ward MH, Graubard BI, et al. Dietary patterns and adenocarcinoma of the esophagus and distal stomach. Am J Clin Nutr 2002;75:137-44.
7. Menges M, Muller M, Zeitz M. Increased acid and bile reflux in Barrett's esophagus compared to reflux esophagitis, and effect of proton pump inhibitor therapy. Am J Gastroenterol 2001;96:331-7.
8. Dixon MF, Neville PM, Mapstone NP, Moayyedi P, Axon ATR. Bile reflux gastritis and Barrett's oesophagus: further evidence of a role for duodeno-gastro-oesophageal reflux? Gut 2001;49:359-63.
9. Orlando RC. Mechanisms of epithelial injury and inflammation in gastrointestinal diseases. Rev Gastroenterol Disord 2002;2:S2-8.
10. Jolly AJ, Wild CP, Hardie LJ. Acid and bile salts induce DNA damage in human oesophageal cell lines. Mutagenesis 2004;19:319-24.
11. Olyaee M, Sontag S, Salman W, et al. Mucosal reactive oxygen species production in esophagitis and Barretts-esophagus. Gut 1995;37:168-73.
12. Shirvani VN, Ouatu-Lascar R, Kaur BS, Omary MB, Triadafilopoulos G. Cyclooxygenase 2 expression in Barrett's esophagus and adenocarcinoma: ex vivo induction by bile salts and acid exposure. Gastroenterology 2000;118:487-96.
13. Iijima K, Henry E, Moriya A, Wirz A, Kelman AW, Mccoll KEL. Dietary nitrate generates potentially mutagenic concentrations of nitric oxide at the gastroesophageal junction. J Gastroenterol 2002;122:1248-57.
14. Wetscher GJ, Hinder RA, Klingler P, Gadenstatter M, Perdikis G, Hinder PR. Reflux esophagitis in humans is a free radical event. Dis Esophagus 1997;10:29-32; discussion 33.
15. Fountoulakis A, Martin IG, White KLM, Cade J, Sue-Ling HM, Wild CP. Plasma and oesophageal mucosal levels of vitamin C: role in the pathogenesis and neoplastic progression of Barrett's oesophagus. Dig Dis Sci 2004;49:914-9.
16. Chen X, Ding YW, Yang G, Bondoc F, Lee MJ, Yang CS. Oxidative damage in an esophageal adenocarcinoma model with rats. Carcinogenesis 2000;21:257-63.
17. Olliver JR, Wild CP, Sahay P, Dexter S, Hardie LJ. Chromoendoscopy with methylene blue and associated DNA damage in Barrett's oesophagus. Lancet 2003;362:373-4.
18. Olliver JR, Hardie LJ, Dexter S, Chalmers D, Wild CP. DNA damage levels are raised in Barrett's oesophageal mucosa relative to squamous epithelium of the oesophagus. Biomarkers 2004;8:509-21.
19. Al Kasspooles MF, Hill HC, Nava HR, Smith JL, Douglass HO, Gibbs JF. High-grade dysplasia within Barrett's esophagus: controversies regarding clinical opinions and approaches. Ann Surg Oncol 2002;9:222-7.
20. Collins AR, Dobson VL, Dusinska M, Kennedy G, Stetina R. The comet assay: what can it really tell us? Mutat Res 1997;375:183-93.
21. Sihvo EI, Salminen JT, Rantanen TK, et al. Oxidative stress has a role in malignant transformation in Barrett's oesophagus. Int J Cancer 2002; 102:551-5.
22. Kaur BS, Ouatu-Lascar R, Omary MB, Triadafilopoulos G. Bile salts induce or blunt cell proliferation in Barrett's esophagus in an acid-dependent fashion. Am J Physiol Gastrointest Liver Physiol 2000;278:G1000-9.
23. Bartsch H, Nair U, Risch A, Rojas M, Wikman H, Alexandrov K. Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers. Cancer Epidemiol Biomarkers Prev 2000;9:3-28.
24. Naidoo R, Chetty R. DNA repair gene status in oesophageal cancer. J Clin Pathol-Mol Pathol 1999;52:125-30.
25. Ouatu-Lascar R, Triadafilopoulos G. Complete elimination of reflux symptoms does not guarantee normalization of intraesophageal acid reflux in patients with Barrett's esophagus. Am J Gastroenterol 1998;93:711-6.
26. Stoner GD, Gupta A. Etiology and chemoprevention of esophageal squamous cell carcinoma. Carcinogenesis 2001;22:1737-46.
27. Kelley JR, Duggan JM. Gastric cancer epidemiology and risk factors. J Clin Epidemiol 2003;56:1-9.
28. Farrow DC, Vaughan TL, Hansten PD, et al. Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer. Cancer Epidemiol Biomarkers Prev 1998;7:97-102.
29. Wilson KT, Fu S, Ramanujam KS, Meltzer SJ. Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in Barrett's esophagus and associated adenocarcinomas. Cancer Res 1998;58:2929-34.